Maternal, newborn, & child health are among Panax core areas of expertise. Panax has a panel of experts with core areas of expertise in maternal, newborn and child health interventions that reach women across the continuum from pre-pregnancy during pregnancy through the postpartum period and newborns through childhood, at each level of the health system, including at the community level.


Every year, millions of children under five die of preventable diseases. Pneumonia and diarrhea alone are responsible for 29 percent of these deaths. While daunting, the commitment of the global community to end this loss of life is achievable through simple, proven, and effective interventions. Panax experts have experience of working at the global, national, subnational, and community levels to expand immunization coverage and improve case management of childhood pneumonia, diarrhea, and malaria.
Immunization is one of the best ways to protect children from disease, yet one out of five infants—many from the poorest, hardest to reach, and most vulnerable families—are not vaccinated. At the same time, even though we know of effective treatment interventions, pneumonia and diarrhea claim the lives of two million children each year who do not receive the simple, life-saving treatment they need.
Strategies for tackling low immunization and deaths due to pneumonia, diarrhea, and malaria include working at various levels— from government to the household—to generate demand for services, assure access to commodities, and strengthen health systems in the treatment of preventable illnesses. This includes expanding immunization services and training and supervising health care providers in effective treatment and case management protocols in both the public and private sectors.
To increase the coverage of routine immunizations, and the roll-out of new vaccines, Panax experts have experience of working with national and subnational governments through two approaches. We have experience of mobilizing the community, educate the public, and eliminate social and financial barriers to increase demand for immunizations within the population. We also can strengthen community outreach and immunization services in government and private health facilities.
Panax has the experience of working with the national government, health care providers, and community health workers to improve case management of childhood pneumonia, diarrhea, and malaria. Our experts have hands on experience of work including community-based administration of oral rehydration solution and zinc for diarrhea treatment, the use of antibiotics for uncomplicated pneumonia, inpatient care for the treatment of severe pneumonia, and use of rapid diagnostic tests for malaria followed by treatment with artemisinin combination therapy for those who test positive.


Panax has extensive experience of promoting and implementing a systems-strengthening approach to increase access and appropriate use of essential maternal, newborn, and child health (MNCH) medicines and supplies that addresses pharmaceutical management taking into account the other five building blocks of health systems: governance, human resources, information systems, financing, and service delivery.


Ensuring availability of quality medicines and supplies requires improving policies, enforcing compliance with policies, and strengthening the regulatory system. Panax has experts available who have worked with national regulatory authorities to streamline medicine registration processes, strengthen quality assurance, align national essential medicines lists with standard treatment guidelines, and establish transparent systems.


Scarcity of well-trained personnel to manage medicines and supplies and provide adequate pharmaceutical services is a perennial problem in developing countries. Providers at lower levels of the health system including the community provide the bulk of MNCH health services, but are often the providers who receive the least attention in terms of capacity building. Panax experts have hands on experience in training through state-of-the-art tools and job aids to assist providers in managing medicines and supplies and providing pharmaceutical services. Panax can implement MCH training programs and accompanying tools on pharmaceutical management for providers at all levels of the system.


Policymakers are often forced to make uninformed decisions about access to MNCH commodities because the necessary information is simply unavailable. Panax has extensive experience of establishing and operationalizing at all levels to improve the evidence base for decision making related to pharmaceutical management.


Most MNCH commodities are inexpensive compared with those needed for other major public health conditions, such as Hepatitis, Tuberculosis, and HIV/AIDS. However, country budgets are often insufficient to cover needs completely. As a result, out-of-pocket expenses increase and equity diminishes for the most vulnerable populations who struggle to access medicines and services. Panax has available experts who can help national programs develop mechanisms that reduce financial barriers, efficiently using existing resources, and generating additional financial resources.


Managing the supply chain is not enough to ensure that patients receive and take the medicines that they need. Providing MNCH services requires provider training on the appropriate administration of medicines and support systems. Panax has experts available who have extensive experience in this area i.e. to promote that pharmaceutical care is included in international and national guidance on best practices.


Panax’s available experts have worked with governments and partners to develop strategies to deliver a wide range of services to end preventable maternal and newborn deaths. Our expert’s developed interventions reach women across the continuum of care—from pre-pregnancy through the postpartum period—and newborns through childhood. These interventions are integrated with family planning and HIV, tuberculosis, and malaria services, with attention to quality and respectful care within communities and in every other level of the health system.
Each year the world continues to lose almost 300,000 mothers as a result of preventable causes related to pregnancy and childbirth. Among newborns, almost 3 million deaths occur within the first week of life. Yet for millions of mothers in low-resource settings, antenatal care is not routine, births are unattended, and postpartum care is nonexistent.
Ending this loss of life to preventable causes and improving maternal and newborn health is possible through the implementation of proven interventions. To this end, Panax has the capacity to build the capacity of local stakeholders, create national guidelines, mobilize communities, build workforces of health providers, improve quality of care in health facilities for family planning and case management, apply and use mobile technologies, and improve pharmaceutical management.
Panax experts have assisted in the development of guidelines on maternal and newborn care and trained government trainers on their use; supported the updating of the national guidelines for maternal and newborn care; the case management of obstetric and neonatal complications; the use of Kangaroo Mother Care; and immediate initiation of exclusive breastfeeding.